Main Menu
Menu

Blog

Publish Date
BlogFact Checks
Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act

A coalition of anti-patent groups — including the R Street Institute, the Electronic Frontier Foundation, Public Knowledge, and others — recently sent...

Blog
C4IP Coalition Updates: November 2025

November Highlights: The Upcoming Review of the USMCA This fall marked the beginning of the first scheduled Joint Review process for the...

Blog
This Month in IP: November 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From gardening...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

Blog
Inventor Spotlight: Ronald Rivest, Adi Shamir, and Leonard Adleman

C4IP is honoring Ronald Rivest (born 1947), Adi Shamir (b. 1952), and Leonard Adleman (b. 1945), whose invention of RSA cryptography forms...

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

Blog
‘Tis the Season — of Counterfeits?

Counterfeiting is a multi-billion-dollar enterprise that puts consumers at serious risk. Poorly-made laptop batteries can overheat. Knock-off cosmetics may contain toxic chemicals....

Blog
This Month in IP: October 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From firefighting...

Blog
C4IP Coalition Updates: October 2025

October Highlights: C4IP Advocates for the Patent Eligibility Restoration Act On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a...

Blog
Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Blog
Highlights from the October 8 PERA Hearing

On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the Patent Eligibility Restoration Act (PERA) to examine...

Blog:

Blog, Fact Checks:

Fact Check: There Is No Patent Quality Crisis,

04/18/2023
Blog:

Blog:

Inventor Spotlight: Ronald J. Harp,

04/13/2023
Blog:

Blog:

Inventor Spotlight: Chester Greenwood,

04/10/2023
Blog:

Blog:

Biden’s Cancer Moonshot Won’t Get off the Ground Without Strong IP Protections,

04/05/2023
Blog:

Blog:

Inventor Spotlight: Bob Born, the “Father of Peeps”,

03/15/2023
Blog:

Blog:

Digital Piracy Throws Creative Ecosystem into Disarray,

03/08/2023
Blog:

Blog, Fact Checks:

Fact Check: Proposed FTC Rule to Ban Non-Competes Will Hamper Innovation,

03/03/2023
Blog:

Blog:

C4IP Co-Sponsors 118th Congress Welcome Reception, featuring the Creative Rights Caucus,

03/02/2023
Blog:

Blog:

Strong IP Rights are Needed to Protect the Next Stevie Wonder, Mary J. Blige,

02/06/2023
Blog:

Blog:

America’s patent system isn’t broken — so it doesn’t need “fixing”,

02/06/2023
Blog:

Blog:

New Letter from Congress Threatens Innovation Ecosystem,

01/23/2023
Blog:

Blog:

The counterfeiters who steal Christmas,

12/15/2022
Scroll to Top